Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Craig Markell who wrote (1473)	1/2/1998 1:04:00 AM
From: Bill Wexler	Respond to of 7041

<<<Just finished reading the paper. It read well, and was basically just what Joe said it would be in the last conference call. I was a good cronological explanation of the development of Vasomax. It does go into some detail of all the patent issues, trial results, and marketing strategies, but really does not expand on most of the data and information we have already seen. This I'm sure is at the request/insistance of SGP. Obviously, for the purpose of not giving the competition to much information.>> ROFLMAO!!! In other words...the same old lies. Short this fraud to zero.